NEOSTIGMINE PROLONGS ANALGESIA IN PERIPHERAL NERVE BLOCK: A META-ANALYSIS. Background and aims: Background: Neostigmine- as an acetylcholinesterase inhibitor- can increase the acetylcholine receptors located on the dorsal horns inducing analgesia; the use of neostigmine as an adjuvant in locoregional anaesthesia showed a dose-dependent analgesic effect even if associated with nausea and vomiting. The intra-articular administration of neostigmine showed a significant analgesic effect; it is presumable that neostigmine can also be used as an adjuvant in the peripheral blocks.We performed a meta-analysis to assess the efficacy of peripherally administered neostigmine on the duration of analgesia and side-effects when supplemented to local anesthetics for peripheral nerve blocks. Objective:We performed a meta-analysis to assess the efficacy of peripherally administered neostigmine on the duration of analgesia and side-effects when added to local anesthetics for peripheral nerve blocks. Methods: Design: A meta-analysis of randomized-controlled human trials. Data sources: Google Scholar and PubMed were searched (updated May 25th, 2014). Authors and external experts were contacted. Eligibility criteria: Inclusion criteria for potentially relevant studies were: random allocation to treatment, comparison of neostigmine administered in peripheral nerve block versus placebo; experimental design with approval of Ethical Committee. Results: The use of neostigmine as adjuvant in the peripheral nerve block could prolong the duration of analgesia: + 47.88 min [CI: 21.86 –74.08 min] of analgesic effect, p for effect 0.0003; p for heterogeneity 0.69; I2=0%. The risk of nausea is not increased: 6/116 in neostigmine group vs 0/145 episodes in control arm; OR 5.34; 95% CI 0.89-31.89, p for effects 0.07, p for heterogeneity 1.00; I2= 0%). Conclusions: Peripherally administered neostigmine might prolong the duration of analgesia without increasing side effects, particularly nausea.

Abstracts and Highlight Papers of the 33rd Annual European Society of Regional Anaesthesia & Pain Therapy (ESRA) Congress 2014

Sales, G.
2014-01-01

Abstract

NEOSTIGMINE PROLONGS ANALGESIA IN PERIPHERAL NERVE BLOCK: A META-ANALYSIS. Background and aims: Background: Neostigmine- as an acetylcholinesterase inhibitor- can increase the acetylcholine receptors located on the dorsal horns inducing analgesia; the use of neostigmine as an adjuvant in locoregional anaesthesia showed a dose-dependent analgesic effect even if associated with nausea and vomiting. The intra-articular administration of neostigmine showed a significant analgesic effect; it is presumable that neostigmine can also be used as an adjuvant in the peripheral blocks.We performed a meta-analysis to assess the efficacy of peripherally administered neostigmine on the duration of analgesia and side-effects when supplemented to local anesthetics for peripheral nerve blocks. Objective:We performed a meta-analysis to assess the efficacy of peripherally administered neostigmine on the duration of analgesia and side-effects when added to local anesthetics for peripheral nerve blocks. Methods: Design: A meta-analysis of randomized-controlled human trials. Data sources: Google Scholar and PubMed were searched (updated May 25th, 2014). Authors and external experts were contacted. Eligibility criteria: Inclusion criteria for potentially relevant studies were: random allocation to treatment, comparison of neostigmine administered in peripheral nerve block versus placebo; experimental design with approval of Ethical Committee. Results: The use of neostigmine as adjuvant in the peripheral nerve block could prolong the duration of analgesia: + 47.88 min [CI: 21.86 –74.08 min] of analgesic effect, p for effect 0.0003; p for heterogeneity 0.69; I2=0%. The risk of nausea is not increased: 6/116 in neostigmine group vs 0/145 episodes in control arm; OR 5.34; 95% CI 0.89-31.89, p for effects 0.07, p for heterogeneity 1.00; I2= 0%). Conclusions: Peripherally administered neostigmine might prolong the duration of analgesia without increasing side effects, particularly nausea.
2014
39
S1 - ESRA1-0625
314
314
&NA;, null; Sales, G.
File in questo prodotto:
File Dimensione Formato  
Neostigmina.pdf

Accesso riservato

Descrizione: PDF
Tipo di file: PDF EDITORIALE
Dimensione 363.89 kB
Formato Adobe PDF
363.89 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1954124
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact